Hospitals and health systems are largely using artificial intelligence for purposes like patient scheduling and disease prediction, several digital and data executives told Becker's.
Innovation
Pharmaceutical company GSK has paid $70 million to partner with precision medicine company Tempus.
Prenuvo, a medical imaging company specializing in early disease detection, has raised $70 million in series A fundraising and debt financing.
EngagedMD, a software company specializing in the fertility space, has raised $11 million in financing.
Pfizer has made a $35 million investment — through its Pfizer "Breakthrough Growth Initiative" — in autoimmune disease treatment biotechnology company Anokion.
Mayo Clinic topped off a $120-million, 11-story research tower in downtown Rochester, Minn., that aims to make scientific breakthroughs for diseases such as cancer.
Cleveland Clinic and IBM are deploying a healthcare quantum computer at the hospital's main campus.
Los Angeles-based Cedars-Sinai joined a $31 million funding round for Vita Therapeutics, a company that uses genetics to develop new cellular therapies to treat muscular dystrophy and cancer.
Minneapolis-based Allina Health has launched hospital-at-home company Inbound Health with a $20 million investment.
Biotechnology company Surge Therapeutics raised $26 million in series A financing.